HC

Hsiu Chiung Yang

Active Director Director DIN 08066600
DIN 08066600 First appointment Feb 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Hsiu Chiung Yang

Data last updated:

Hsiu Chiung Yang is a Director at Biodenta India Private Limited (since 2018). The company operates in Healthcare. Biodenta India Private Limited reported revenue of ₹5 Lakh (FY 2019).

DIN 08066600
Primary Designation Director
Industry Healthcare
First Appointment 08 Feb 2018
Oldest Company Age 13 yrs
Largest company Biodenta India Private Limited · ₹5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biodenta India Private Limited U33110DL2013FTC247013
Director08 Feb 20182013₹5 Lakh (FY 2019)Active

Board colleagues of Hsiu Chiung Yang

Directorship timeline

Open interactive timeline →
Biodenta India Private Limited
Premium access

Shareholding and investment profile for Hsiu Chiung Yang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hsiu Chiung Yang

Hsiu Chiung Yang currently holds 1 directorship: Biodenta India Private Limited (Director, since 08 Feb 2018, revenue ₹5 Lakh (FY 2019)).

Hsiu Chiung Yang was first appointed on 08 Feb 2018 as Director at Biodenta India Private Limited.

The current boards of Hsiu Chiung Yang's companies include Pei Hsung Hsieh (Biodenta India Private Limited), Vineet Arora (Biodenta India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available